CRAIG R STAPLETON
CIK 1207106 · See Remarks · last filed 2018-08-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.92M
Companies
3
Total Filings
48
Lifetime Open-Market Net
$2.19M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Director | 588,628 | $21.64 | $12.74M | -$668.0K | 14 | 2018-08-02 |
| ANF | Director | 57,398 | $103.16 | $5.92M | $942.2K | 20 | 2017-06-16 |
| AVADEL PHARMACEUTICALS PLC (FLML) Delisted | Director | 508,878 | — | — | $1.92M | 8 | 2017-01-03 |
Recent Filings · Page 2 of 5
48 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-05-18 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Grant (A) | +15,570 | $155.1K | EDGAR |
| 2017-05-16 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Grant (A) | +3,417 | $34.2K | EDGAR |
| 2017-04-05 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Grant (A) | +15,000 | $143.6K | EDGAR |
| 2017-02-24 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Grant (A) | +548,878 | $0 | EDGAR |
| 2017-01-13 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Grant (A) | +548,878 | $0 | EDGAR |
| 2017-01-03 | AVADEL PHARMACEUTICALS PLC (FLML) Delisted | Grant (A) | +548,878 | $0 | EDGAR |
| 2017-01-03 | AVADEL PHARMACEUTICALS PLC (FLML) Delisted | Disp (D) | −548,878 | $0 | EDGAR |
| 2016-12-20 | AVADEL PHARMACEUTICALS PLC (FLML) Delisted | Gift (G) | −10,800 | $0 | EDGAR |
| 2016-11-30 | AVADEL PHARMACEUTICALS PLC (FLML) Delisted | Buy (P) | +20,000 | $215.9K | EDGAR |
| 2016-09-06 | ANF | Buy (P) | +10,000 | $176.5K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.